|
시장보고서
상품코드
2077316
COVID-19 검출 키트 시장 : 제품 유형별, 검체 유형별, 최종사용자별, 지역별COVID-19 Detection Kits Market, By Product Type, By Specimen Type, By End User, By Geography |
||||||
COVID-19 검출 키트 시장은 2026년에 47억 4,000만 달러 규모에 달할 것으로 추정되며, 2033년에 56억 7,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 2.6%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 47억 4,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026-2033년까지 예측 기간의 CAGR: | 2.60 | 2033년 시장 규모 예측: | 56억 7,000만 달러 |
COVID-19 검출 키트는 두 가지 방법을 통해 SARS-CoV-2(신종 코로나바이러스)를 확인할 수 있습니다. 첫 번째는 바이러스 자체의 존재를 검출하는 RT-PCR법이며, 두 번째는 감염에 따라 생성되는 항체를 검출하는 면역측정법입니다. 바이러스의 추가 확산을 막기 위해 전 세계 정부와 규제 당국은 가능한 한 많은 COVID-19 검사를 실시하는 데 주력하고 있으며, 그 결과 전 세계적으로 COVID-19 검출 키트에 대한 수요가 증가하고 있습니다. 예를 들어, 2020년 4월 4일, 영국 보건·사회복지부는 국민보건서비스(NHS)가 지금까지 약 20만 건의 검사를 실시했으며, 영국 내 검사 능력을 하루 5,000건에서 1만 건으로 확대했다고 보고했습니다. 같은 소식통에 따르면, NHS는 4월 말까지 영국 내 일일 면봉 검사 능력을 2만 5,000건 가까이까지 확대할 계획입니다. 따라서, COVID-19 검사 수요의 증가가 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다.
시장 역학
주요 기업들이 COVID-19 진단 키트의 생산 확대를 도모하기 위해 제휴 및 공동 개발과 같은 비유기적 성장 전략을 적극적으로 채택하고 있는 점이, 예측 기간 동안의 시장 성장을 뒷받침할 것으로 전망됩니다. 예를 들어, 2020년 4월 14일, 분자진단 기업인 Co-Diagnostics, Inc.는 분자진단용 부품 공급업체인 Promega Corporation과 제휴하여 'Logix Smart COVID-19' 검출 키트의 생산 확대를 추진했습니다. 이번 제휴를 통해 Co-Diagnostics, Inc.는 COVID-19 진단 키트에 대한 수요를 충족시키는 동시에 미국 시장에서의 입지를 강화하게 될 것입니다.
이와 마찬가지로, 2020년 4월 29일, Centene Corporation은 진단 정보 서비스 제공업체인 Quest Diagnostics와 제휴하여 미국 내 실시간 역전사 중합효소 연쇄 반응(rRT-PCR)을 이용한 COVID-19 검사 제공 체계를 확충했습니다. 이번 제휴를 통해 Centene는 매주 약 2만 5,000개의 Quest사 COVID-19 검사 키트를 미국 전역 10개 주 또는 지역에 위치한 연방 공인 의료 센터(FQHC)에 배포하게 됩니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신약 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음 매개변수를 바탕으로 전 세계 COVID-19 검출 키트 시장의 주요 기업 개요을 작성하고 있습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 시장 내 입지, 유통 전략, 주요 개발 사항, 전략, 향후 계획입니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 의약품 출시, 검사 항목 확충, 시장 확대, 마케팅 전략에 관해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- '전 세계 COVID-19 검출 키트 시장' 보고서는 투자자, 공급업체, 제약사, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 COVID-19 검사 키트 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 RT-PCR 어세이 키트
제5장 면역측정용 테스트 스트립/카세트
제6장 비인두 면봉
제7장 구강인두 면봉
제8장 비강 면봉
제9장 객담
제10장 기타
제11장 병원
제12장 진단 센터
제13장 기타
제14장 북미
제15장 유럽
제16장 아시아태평양
제17장 라틴아메리카
제18장 중동
제19장 아프리카
제20장 경쟁 구도
제21장 섹션
KSM 26.07.10COVID-19 Detection Kits Market is estimated to be valued at USD 4.74 Bn in 2026 and is expected to reach USD 5.67 Bn by 2033, growing at a compound annual growth rate (CAGR) of 2.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.74 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 2.60% | 2033 Value Projection: | USD 5.67 Bn |
COVID-19 detection kits can identify the SARS-CoV-2 or coronavirus through two methods. The first method is the RT-PCR method in which the presence of the virus itself is detected and the second is an immunoassay test which detects antibodies produced in response to the infection. In order to prevent further spread of the virus, governments and regulatory authorities all over the world are focusing on conducting maximum number of COVID-19 detection tests which has led to a high demand for COVID-19 detection kits globally. For instance, on April 04, 2020, the Department of Health and Social Care, UK, reported that National Health Service has conducted around 200,000 tests so far and has also scaled up the testing capacity from 5,000 to 10,000 tests per day in the U.K. According to the same source, the National Health Service is planning to increase the capacity to nearly 25,000 swab tests per day by the end of April in the U.K. Hence, the increasing demand for COVID-19 detection is expected to boost the market growth during the forecast period.
Market Dynamics
The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players to increase the production of COVID-19 tests is expected to propel the market growth during the forecast period. For instance, on April 14, 2020, Co-Diagnostics, Inc., a molecular diagnostics company, collaborated with Promega Corporation, a provider of molecular diagnostic components, to amplify the production of Logix Smart COVID-19 tests. This collaboration will allow Co-Diagnostics, Inc. to meet the demand for COVID-19 tests and strengthen its presence in the U.S.
Similarly, on April 29, 2020, Centene Corporation collaborated with Quest Diagnostics, provider of diagnostic information services to increase availability of real-time reverse transcription polymerase chain reaction (rRT-PCR) COVID-19 testing in the U.S. Through this collaboration, Centene will distribute around 25,000 Quest COVID-19 test kits every week to Federally Qualified Health Centers (FQHCs) in ten states or districts across the U.S.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global COVID-19 detection kits market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study are Co-Diagnostics, Inc F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific, Abbott Laboratories, BGI, Cepheid Inc, BioFire Diagnostics, GenMark Diagnostics, Qiagen, Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, INC., Shenzhen Bioeasy Biotechnology Co., Ltd., and Seegene Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, Specimen Type up-gradation, market expansion, and marketing tactics
- The global COVID-19 detection kits market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global COVID-19 detection kits market
Detailed Segmentation:
- Global COVID-19 detection kits Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- RT-PCR Assay Kits
- Immunoassay Test Strips/Cassettes
- Global COVID-19 detection kits Market, By Specimen Type (Revenue, USD Bn, 2021 - 2033)
- Nasopharyngeal swab
- Oropharyngeal swab
- Nasal swab
- Sputum
- Others
- Global COVID-19 detection kits Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Diagnostic centers
- Others
- Global COVID-19 detection kits Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Product Type
- RT-PCR Assay Kits
- Immunoassay Test Strips/Cassettes
- By Specimen Type:
- Nasopharyngeal swab
- Oropharyngeal swab
- Nasal swab
- Sputum
- Others
- By End User:
- Hospitals
- Diagnostic centers
- Others
- By Country:
- U.S.
- Canada
- By Product Type
- Latin America
- By Product Type
- RT-PCR Assay Kits
- Immunoassay Test Strips/Cassettes
- By Specimen Type:
- Nasopharyngeal swab
- Oropharyngeal swab
- Nasal swab
- Sputum
- Others
- By End User:
- Hospitals
- Diagnostic centers
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Product Type
- Europe
- By Product Type
- RT-PCR Assay Kits
- Immunoassay Test Strips/Cassettes
- By Specimen Type:
- Nasopharyngeal swab
- Oropharyngeal swab
- Nasal swab
- Sputum
- Others
- By End User:
- Hospitals
- Diagnostic centers
- Others
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Product Type
- Asia Pacific
- By Product Type
- RT-PCR Assay Kits
- Immunoassay Test Strips/Cassettes
- By Specimen Type:
- Nasopharyngeal swab
- Oropharyngeal swab
- Nasal swab
- Sputum
- Others
- By End User:
- Hospitals
- Diagnostic centers
- Others
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Product Type
- Middle East
- By Product Type
- RT-PCR Assay Kits
- Immunoassay Test Strips/Cassettes
- By Specimen Type:
- Nasopharyngeal swab
- Oropharyngeal swab
- Nasal swab
- Sputum
- Others
- By End User:
- Hospitals
- Diagnostic centers
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Product Type
- Africa
- By Product Type
- RT-PCR Assay Kits
- Immunoassay Test Strips/Cassettes
- By Specimen Type:
- Nasopharyngeal swab
- Oropharyngeal swab
- Nasal swab
- Sputum
- Others
- By End User:
- Hospitals
- Diagnostic centers
- Others
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Product Type
- Company Profiles
- Co-Diagnostics, Inc*
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Hoffmann-La Roche AG
- Siemens Healthineers AG
- Thermo Fisher Scientific
- Abbott Laboratories
- BGI
- Cepheid Inc
- BioFire Diagnostics
- GenMark Diagnostics
- Qiagen
- Quidel Corporation
- Randox Laboratories Ltd.
- SD Biosensor, INC.
- Shenzhen Bioeasy Biotechnology Co., Ltd.
- Seegene Inc.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Specimen Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. RT-PCR Assay Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
5. Immunoassay Test Strips/Cassettes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
6. Nasopharyngeal swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
7. Oropharyngeal swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
8. Nasal swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
9. Sputum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
10. Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
11. Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
12. Diagnostic centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
13. Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
14. North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- U.S.
- Canada
15. Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
16. Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
17. Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
18. Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
19. Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021-2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
20. Competitive Landscape
- Company Profiles
- Co-Diagnostics, Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Siemens Healthineers AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- BGI
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cepheid Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- BioFire Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- GenMark Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Qiagen
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Quidel Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Randox Laboratories Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- SD Biosensor, INC.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Shenzhen Bioeasy Biotechnology Co., Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Seegene Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- JOYSBIO Biotechnology
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cipla Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bione
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Virax Biolabs Group Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- SD BioSensor, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- NanoSpot.ai
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- J. Mitra & Co. Pvt. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Genes2Me
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Ubio Biotechnology Systems Pvt Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bharat Biotech
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Gennova Biopharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- QRX Pharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Angstrom Biotech Pvt. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Detect, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Co-Diagnostics, Inc.*
21. Section
- References
- Research Methodology
- About us and Sales Contact
